The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk ...

FDA oral Wegovy, solid fundamentals, and low P/E vs. Eli Lilly. Click for this updated look at NVO stock prospects as ...

Patients on tirzepatide also experienced more metabolic benefits, such as greater reductions in weight and HbA1c, compared with dulaglutide.

Doctors in the UAE have welcomed the news that anti-obesity drug Wegovy is set to become available as a pill as well as an injection, but have cautioned that it should only be taken under expert ...

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...

Mounjaro (tirzepatide) is a prescription drug for adults with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation was reported in 6% to ...

India's obesity drug market expected to exceed $1 billion in two years, analyst says Lilly's Mounjaro leads in sales, Novo cuts prices to compete Lilly and Novo partner with local firms to expand ...

Arrowhead Pharmaceuticals reported early trial data showing notable reductions in body, liver, and visceral fat from two experimental obesity drugs, with more results expected in 2026.

People thought Charli-Dee's weight loss was "motivational" and described her slimmed down look as "amazing" A WOMAN has revealed that she went from a size 14 to a size 6 in just four months on ...

Shares of Eli Lilly and Co. slumped toward their biggest selloff in more than three years on Wednesday, after the drugmaker reported third-quarter results that missed expectations, due to big misses ...

SHANGHAI, Dec 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the ...